Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Exact Sciences Corp (EXAS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013850
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates a laboratory facility in Madison, Wisconsin to process Cologuard tests. Exact is headquartered in Madison, Wisconsin, the US.

Exact Sciences Corp (EXAS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exact Sciences Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exact Sciences Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exact Sciences Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exact Sciences Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Exact Sciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exact Sciences Corp, Medical Equipment, Deal Details 10
Asset Purchase 10
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 10
Partnerships 11
Exact Sciences Amends Licensing Agreement with Mayo Clinic 11
Exact Sciences Expands Licensing Agreement With Mayo Clinic 12
MDxHealth Enters Into Licensing Agreement With Exact Sciences 13
MDxHealth Enters into Agreement with Exact Sciences 14
Equity Offering 15
Exact Sciences Raises USD245 Million in Public Offering of Shares 15
Exact Sciences Prices Public Offering of Shares for USD132 Million 17
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 18
Exact Sciences Prices Public Offering of Shares for USD103 Million 19
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 20
Exact Sciences Completes Public Offering Of Shares For US$78 Million 22
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 23
Exact Sciences Completes Underwritten Public Offering Of Common Stock For US$29 Million 24
Exact Sciences Corp – Key Competitors 26
Exact Sciences Corp – Key Employees 27
Exact Sciences Corp – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Financial Announcements 29
Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests 29
Feb 21, 2017: Exact Sciences reports lower Q4 net loss, provides outlook for 2017 30
Feb 24, 2016: Exact Sciences Reports Fourth Quarter and Full Year 2015 Results 31
Jan 11, 2016: Exact Sciences Announces Preliminary Fourth Quarter and Full Year 2015 Results 32
Corporate Communications 33
Nov 08, 2016: Exact Sciences Appoints Jeff Elliott Chief Financial Officer 33
Product News 34
02/25/2016: Anthem BCBS Georgia and Virginia Contracted to Cover Cologuard as In-Network Service 34
02/23/2016: Modeling Data Supports Cologuard Use Every Three Years 35
02/19/2016: Routine Annual Screening for Colorectal Cancer Not Achieved by Fecal Blood Tests 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Exact Sciences Corp, Medical Equipment, Key Facts, 2016 2
Exact Sciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Exact Sciences Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Exact Sciences Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Exact Sciences Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Exact Sciences Corp, Deals By Market, 2011 to YTD 2017 8
Exact Sciences Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Exact Science to Acquire Biomarker and Technology Patents from MdxHealth for USD15 Million 10
Exact Sciences Amends Licensing Agreement with Mayo Clinic 11
Exact Sciences Expands Licensing Agreement With Mayo Clinic 12
MDxHealth Enters Into Licensing Agreement With Exact Sciences 13
MDxHealth Enters into Agreement with Exact Sciences 14
Exact Sciences Raises USD245 Million in Public Offering of Shares 15
Exact Sciences Prices Public Offering of Shares for USD132 Million 17
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 18
Exact Sciences Prices Public Offering of Shares for USD103 Million 19
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 20
Exact Sciences Completes Public Offering Of Shares For US$78 Million 22
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 23
Exact Sciences Completes Underwritten Public Offering Of Common Stock For US$29 Million 24
Exact Sciences Corp, Key Competitors 26
Exact Sciences Corp, Key Employees 27
Exact Sciences Corp, Subsidiaries 28

★海外企業調査レポート[Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Biogened SA-製薬・医療分野:企業M&A・提携分析
    Summary BIOGENED SA (Biogened) is a drug company that develops, produces, and distributes Rx medicines and dietary supplements. The company’s products include recipes dermocosmetic products, specialized products, active ingredients, pharmaceutical products, and cosmetic products. Its also offers nov …
  • Lipocine Inc (LPCN):製薬・医療:M&Aディール及び事業提携情報
    Summary Lipocine Inc (Lipocine) is a pharmaceutical company that develops and commercializes treatment for men's and women's health. The company’s pipeline products for men’s health include LPCN 1111 and LPCN 1021; and for women’s health include LPCN 1107. Its LPCN 1111 is an oral testosterone produ …
  • Theranostics Health Inc-医療機器分野:企業M&A・提携分析
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • GrowMax Resources Corp (BOE):企業の財務・戦略的SWOT分析
    Summary GrowMax Resources Corp (GrowMax), formerly Americas Petrogas Inc is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas properties in Argentina. The company explores and develops phosphate and potassium-rich brine resources in northwe …
  • EnergyAustralia Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary EnergyAustralia Pty Ltd (EnergyAustralia), formerly TRUenergy, is an electric utility that invests in energy generation and retailing activities. The company generates electricity and retails power and gas. It produces electricity from coal, gas, solar and wind sources. EnergyAustralia offer …
  • Central Alabama Electric Cooperative Inc:企業の戦略的SWOT分析
    Central Alabama Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • PPL Corp:企業の発電所・SWOT分析2018
    PPL Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executive …
  • Center for Applied Medical Research-製薬・医療分野:企業M&A・提携分析
    Summary Center for Applied Medical Research (CIMA), a subsidiary of University of Navarra is a medical research center that carries out research in the therapeutic areas of cardiovascular sciences, gene therapy and hepatology, oncology and neurosciences. The center also provides support services suc …
  • Motiva Enterprises LLC:企業の戦略的SWOT分析
    Motiva Enterprises LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • International Consolidated Airlines Group, S.A.
    International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary International Consolidated Airlines Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • CLP Holdings Ltd:企業の発電所・SWOT分析2018
    CLP Holdings Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • HealthCare Global Enterprises Ltd (HCG)-製薬・医療分野:企業M&A・提携分析
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that offers medical care and treatment services. The company offers services such as clinical laboratory services, diagnosis services, medical oncology services, radiation …
  • Iconix Brand Group, Inc.:企業のM&A・事業提携・投資動向
    Iconix Brand Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iconix Brand Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析
    Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Isagen SA ESP-エネルギー分野:企業M&A・提携分析
    Summary Isagen SA ESP (Isagen), a subsidiary of Brookfield Renewable Energy Partners LP, is an electricity utility. It generates and markets electricity; supplies natural gas; and sells coal, steam, and other energy sources. The company produces electric energy from hydro and natural gas sources. Is …
  • Walgreens Boots Alliance, Inc.:企業の戦略・SWOT・財務情報
    Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report Summary Walgreens Boots Alliance, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Allied Irish Banks, Plc:戦略・SWOT・企業財務分析
    Allied Irish Banks, Plc - Strategy, SWOT and Corporate Finance Report Summary Allied Irish Banks, Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dechra Pharmaceuticals Plc (DPH):企業の財務・戦略的SWOT分析
    Summary Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes vetoryl, felimazole, thyforon, malaseb, canaural, isaderm, cardisure, comfortan, soludox, methoxasol, cyclospray and octacillin, among others. …
  • Top Kinisis Travel Public Ltd:戦略・SWOT・企業財務分析
    Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Top Kinisis Travel Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ario Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Ario Pharma Ltd (Ario) is a drug development company that develops new therapeutics for the treatment of pain. The company develops small molecule TRPA1 antagonists to treat neuropathic and inflammatory pain. Its TRPA1 activators include pungent or noxious compounds such as allyl isothiocyan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆